From: SARS-CoV-2 viral load is associated with risk of transmission to household and community contacts
 | N (%) or median (range) |
---|---|
Age, years | 21 (18–58) |
Sex | Â |
 Female | 117 (55.5%) |
Viral load (log10 copies per mL) | 5.6 (1.8–10.4) |
 < 5 log10 copies per mL | 75 (35.4%) |
 5–8 log10 copies per mL | 129 (60.8%) |
 > 8 log10 copies per mL | 8 (3.8%) |
Comorbidity | Â |
 Yes | 29 (13.7%) |
  Asthma | 21 (72.4%) |
  Current smoker | 3 (10.3%) |
  Chronic kidney disease | 2 (6.9%) |
  Diabetes | 1 (3.4%) |
  Severe obesity (BMI > 35) | 1 (3.4%) |
  Immunocompromised | 1 (3.4%) |
  Hypertension | 1 (3.4%) |
Symptoms reported at time of investigation | |
 Yes | 167 (78.8%) |
  Congestion or runny nose* | 107 (64.1%) |
  Fatigue* | 72 (43.1%) |
  Cough* | 72 (43.1%) |
  Headache* | 72 (43.1%) |
  Sore throat* | 68 (40.7%) |
  Muscle ache* | 40 (24.0%) |
  Loss of taste or smell* | 36 (21.6%) |
Test relative to symptom onset (N = 167) | |
 Tested prior to symptom onset | 19 (11.4%) |
 Tested on day of onset | 43 (25.7%) |
 Tested after symptom onset | 105 (62.9%) |
University affiliation | Â |
 Student | 200 (94.4%) |
 Staff or Faculty | 12 (5.6%) |